JP2000507578A5 - - Google Patents

Download PDF

Info

Publication number
JP2000507578A5
JP2000507578A5 JP1997535395A JP53539597A JP2000507578A5 JP 2000507578 A5 JP2000507578 A5 JP 2000507578A5 JP 1997535395 A JP1997535395 A JP 1997535395A JP 53539597 A JP53539597 A JP 53539597A JP 2000507578 A5 JP2000507578 A5 JP 2000507578A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997535395A
Other languages
English (en)
Japanese (ja)
Other versions
JP4759762B2 (ja
JP2000507578A (ja
Filing date
Publication date
Priority claimed from US08/626,259 external-priority patent/US5717092A/en
Application filed filed Critical
Publication of JP2000507578A publication Critical patent/JP2000507578A/ja
Publication of JP2000507578A5 publication Critical patent/JP2000507578A5/ja
Application granted granted Critical
Publication of JP4759762B2 publication Critical patent/JP4759762B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53539597A 1996-03-29 1997-03-24 改良された多剤耐性活性を有するｎ―（２―オキソアセチルまたはスルホニル）―ピロリジン／ピペリジン―２―カルボン酸誘導体 Expired - Fee Related JP4759762B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/626,259 1996-03-29
US08/626,259 US5717092A (en) 1996-03-29 1996-03-29 Compounds with improved multi-drug resistance activity
PCT/US1997/004916 WO1997036869A1 (en) 1996-03-29 1997-03-24 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity

Publications (3)

Publication Number Publication Date
JP2000507578A JP2000507578A (ja) 2000-06-20
JP2000507578A5 true JP2000507578A5 (enExample) 2004-12-02
JP4759762B2 JP4759762B2 (ja) 2011-08-31

Family

ID=24509627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53539597A Expired - Fee Related JP4759762B2 (ja) 1996-03-29 1997-03-24 改良された多剤耐性活性を有するｎ―（２―オキソアセチルまたはスルホニル）―ピロリジン／ピペリジン―２―カルボン酸誘導体

Country Status (11)

Country Link
US (2) US5717092A (enExample)
EP (1) EP0891331B1 (enExample)
JP (1) JP4759762B2 (enExample)
AT (1) ATE251140T1 (enExample)
AU (1) AU2346597A (enExample)
CA (1) CA2249369A1 (enExample)
DE (1) DE69725293T2 (enExample)
DK (1) DK0891331T3 (enExample)
ES (1) ES2208890T3 (enExample)
PT (1) PT891331E (enExample)
WO (1) WO1997036869A1 (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150527A (en) * 1994-08-18 2000-11-21 Ariad Pharmaceuticals, Inc. Synthetic multimerizing agents
US6133456A (en) * 1994-08-18 2000-10-17 Ariad Gene Therapeutics, Inc. Synthetic multimerizing agents
US20030036654A1 (en) * 1994-08-18 2003-02-20 Holt Dennis A. Synthetic multimerizing agents
US5795877A (en) * 1996-12-31 1998-08-18 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US6218424B1 (en) * 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
JP2002515051A (ja) * 1996-12-31 2002-05-21 ジーピーアイ エヌアイエル ホールディングス インコーポレイテッド ヘテロ環式チオエステルのｎ−結合スルホンアミド
US5935989A (en) 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
EP0959882A4 (en) * 1996-12-31 2001-12-05 N-LINKED UREAS AND CARBAMATES OF HETEROCYCLIC THIOESTERS
US5874449A (en) * 1996-12-31 1999-02-23 Gpi Nil Holdings, Inc. N-linked sulfonamides of heterocyclic thioesters
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
US5846979A (en) * 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6852496B1 (en) * 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
EP1069897A1 (en) * 1998-04-08 2001-01-24 Eli Lilly And Company Methods for inhibiting mrp1
TR200002851T2 (tr) * 1998-04-08 2000-12-21 Eli Lilly And Company MRP1'i inhibe etmek için yöntemler.
US6410041B1 (en) 1998-04-28 2002-06-25 Trustees Of Tufts College Culturing cells in presence of amphipathic weak bases and/or cations and multiple drug resistance inhibitor containing reserpine
US20020131972A1 (en) * 1998-05-21 2002-09-19 Daniel Sem Multi-partite ligands and methods of identifying and using same
CA2333997A1 (en) 1998-06-02 1999-12-09 Bristol-Myers Squibb Company Neurotrophic difluoroamide agents
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
KR20010052503A (ko) 1998-06-03 2001-06-25 다니엘 피. 맥컬럼 Ｎ-헤테로사이클릭 카복실산 또는 카복실산 등입체의ｎ-결합된 설폰아미드
EP1117635A1 (en) * 1998-09-30 2001-07-25 The Procter & Gamble Company 2-substituted ketoamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6228872B1 (en) 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
US6358531B1 (en) * 1999-02-01 2002-03-19 The Curators Of The University Of Missouri Method for preparing porous shells or gels from glass particles
AU6387500A (en) * 1999-08-05 2001-03-05 Procter & Gamble Company, The Multivalent exocyclic diketo compounds
WO2001027116A2 (en) * 1999-10-07 2001-04-19 Eli Lilly And Company Condensed dihydroquinolinone derivatives for inhibiting mrp1
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
MXPA02006134A (es) 1999-12-21 2002-12-13 Guilford Pharm Inc Compuestos derivados de hidantoina, composiciones farmaceuticas y metodos de uso de los mismos.
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6593362B2 (en) 2001-05-21 2003-07-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US20030203890A1 (en) * 2001-05-29 2003-10-30 Steiner Joseph P. Method for treating nerve injury caused as a result of surgery
US7653490B2 (en) * 2001-09-10 2010-01-26 Triad Liquidating Company LLC Nuclear magnetic resonance assembly of chemical entities
BR0213989A (pt) * 2001-11-07 2005-03-01 Pharmacia Corp Métodos para promover a absorção e acúmulo nuclear de poliamidas em células eucarióticas
US6635892B2 (en) * 2002-01-24 2003-10-21 Pei Electronics, Inc. Compact integrated infrared scene projector
US20030180797A1 (en) * 2002-03-20 2003-09-25 Lin Yu Identification of ligands for a receptor family and related methods
EP1490098B1 (en) * 2002-03-25 2010-03-17 Technologie Biolactis Inc. Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
WO2005007162A1 (en) * 2003-07-10 2005-01-27 Vertex Pharmaceuticals Incorporated Compounds augmenting the activity of antibacterial agents
CN1281210C (zh) * 2003-11-29 2006-10-25 胡汛 五味子乙素在制备治疗肿瘤药物中的应用
US20060189551A1 (en) * 2004-10-04 2006-08-24 Duke University Combination therapies for fungal pathogens
KR20070090913A (ko) * 2004-12-20 2007-09-06 와이어쓰 라파마이신 유사체 및 신경계, 증식성 및 염증성 장애의치료에서의 이들의 용도
WO2006068905A2 (en) * 2004-12-20 2006-06-29 Wyeth Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
JP5767900B2 (ja) 2011-08-24 2015-08-26 株式会社東芝 水中溶接装置及び方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920218A (en) * 1988-10-12 1990-04-24 Merck & Co., Inc. Novel hydroxide mediated FK-506 rearrangement process
DE4015255A1 (de) * 1990-05-12 1991-11-14 Hoechst Ag Oxalyl-aminosaeurederivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel zur inhibierung der prolyl-hydroxylase
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
GB2247456A (en) * 1990-09-03 1992-03-04 Fujisawa Pharmaceutical Co Tetrahydropyrane compounds, a process for their production and a pharmaceutical composition containing the same
HU217621B (hu) * 1991-05-09 2000-03-28 Vertex Pharmaceuticals Inc. Eljárás új glioxaloil-pipekolinsav-észterek, származékaik és az ezeket tartalmazó gyógyszerkészítmények előállítására
US5620971A (en) * 1991-05-09 1997-04-15 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
US5250678A (en) * 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
AU2152092A (en) * 1991-06-24 1993-01-25 Erziehungsdirektion Of The Canton Zurich Neurite growth regulatory factors
EP0660959A4 (en) * 1992-09-07 1998-05-06 Mikoh Technology Ltd Diffraction surface data detector.
NZ314207A (en) * 1992-09-28 2000-12-22 Vertex Pharma 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
ES2245781T3 (es) * 1994-08-18 2006-01-16 Ariad Gene Therapeutics, Inc. Nuevos agentes de multimerizacion.
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity

Similar Documents

Publication Publication Date Title
JP2000515136A5 (enExample)
JP2001502790A5 (enExample)
JP2000505621A5 (enExample)
JP2000515334A5 (enExample)
JP2000508796A5 (enExample)
JP2000504593A5 (enExample)
JP2000507453A5 (enExample)
JP2000504242A5 (enExample)
JP2000507126A5 (enExample)
JP2001503285A5 (enExample)
JP2001504828A5 (enExample)
JP2001506066A5 (enExample)
JP2000508783A5 (enExample)
JP2000515363A5 (enExample)
JP2000507053A5 (enExample)
JP2000507688A5 (enExample)
JP2000506913A5 (enExample)
JP2001507177A5 (enExample)
JP2000509168A5 (enExample)
JP2000517125A5 (enExample)
JP2001503735A5 (enExample)
JP2000504454A5 (enExample)
JP2001503812A5 (enExample)
JP2000509581A5 (enExample)
JP2000505246A5 (enExample)